Brad Ebel is the Executive Director of cGMP Facilities and Engineering and Framingham Site Lead for Internal Manufacturing at CRISPR Therapeutics. Brad has over 20 years of experience in the biopharmaceutical industry spanning Manufacturing, Process Development, Pilot Facility, Site Operations and Finance. While at CRISPR, Brad’s first responsibility was to identify an internal cGMP manufacturing facility in the Greater Boston Area. For this project, his key responsibilities included: identifying a location, securing a lease, and interfacing with the architect, engineering, and construction companies. Brad has been responsible for overseeing the office, lab and GMP facility build, as well as ensuring the commission of the facility is completed on time and within budget. The construction of the CRISPR Therapeutics Framingham Manufacturing Facility is the seventh lab/facility build that Brad has worked on in his career. Brad holds his B.S. in Chemistry for Westminster College.